Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Kidney Neoplasms × Varenicline × 30 days × Clear all

Sponsor

Interventions

cabozantinib 3 Ipilimumab 3 pembrolizumab 2 Sunitinib 2 Nivolumab 2 Blood Specimen Collection 2 Axitinib 2 zimberelimab 1 spartalizumab 1 palbociclib 1 olaparib 1 liposomal doxorubicin 1 atezolizumab 1 aldesleukin 1 adagrasib 1 Taxes 1 Paclitaxel 1 Lomustine 1 Irinotecan 1 Interleukin-2 1 Gemcitabine 1 Doxorubicin 1 Carboplatin 1 Aminolevulinic Acid 1 Albumin-Bound Paclitaxel 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡